You are here

  • Home
  • Archive
  • Volume 11, Issue 9
  • Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events

 

Online download statistics by month:

Online download statistics by month: September 2023 to September 2025

AbstractFullPdf
Sep 202342442385
Oct 202317417666
Nov 202314414449
Dec 202311411560
Jan 2024696936
Feb 2024697038
Mar 2024777769
Apr 2024666645
May 2024464625
Jun 2024737339
Jul 2024676837
Aug 2024484718
Sep 2024525234
Oct 2024424226
Nov 2024535527
Dec 2024646542
Jan 2025404020
Feb 2025858529
Mar 2025595944
Apr 2025878764
May 2025474836
Jun 2025232430
Jul 2025110
Sep 2025110
Total19251933919